Hubbard Radio Washington DC, LLC. All rights reserved. This website is not intended for users located within the European Economic Area.
ROCKVILLE, Md. (AP) _ MacroGenics Inc. (MGNX) on Thursday reported a loss of $39.9 million in its second quarter.
The Rockville, Maryland-based company said it had a loss of 66 cents per share.
The results fell short of Wall Street expectations. The average estimate of six analysts surveyed by Zacks Investment Research was for a loss of 28 cents per share.
The biopharmaceutical company posted revenue of $30.8 million in the period, which also fell short of Street forecasts. Four analysts surveyed by Zacks expected $35.6 million.
Insight by Cloudera: Learn about what a few federal agencies are doing to tackle data security challenges and improve their cyber data posture in this exclusive e-book.
MacroGenics shares have risen 14% since the beginning of the year. In the final minutes of trading on Thursday, shares hit $26.08, a rise of 1% in the last 12 months.
This story was generated by Automated Insights (http://automatedinsights.com/ap) using data from Zacks Investment Research. Access a Zacks stock report on MGNX at https://www.zacks.com/ap/MGNX
© 2021 . All rights reserved. This website is not intended for users located within the European Economic Area.